Compare Cassava Sciences Inc (FLNA) vs PubMatic Inc (PUBM) Price & Performance

FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.

Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.

PubMatic trades at $13.69, up 0.88% with a bullish technical signal from moving averages. The company shows strong revenue stability around $283M (2025) and positive operating cash flow of $81M, though net income remains negative at -$14.46M. Recent product launches like AgenticOS and partnerships signal innovation in digital advertising. Analyst consensus is evenly split between Buy and Hold with a $17 price target, indicating moderate upside potential from current levels.

The outlook balances growth initiatives against profitability challenges. Investment opportunity lies in market share gains from AI-driven ad tech expansion, but risks include persistent negative margins and competitive pressure. Valuation metrics (P/E 132) suggest high expectations that require execution to justify.